| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.75M | - | |
| Dir | 164.0K | $12.45M | -8,000 | |
| VP | 100.3K | $7.61M | - | |
| VP | 83.3K | $6.32M | -60,846 | |
| CFO | 82.7K | $6.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | Cadoret-Manier Onaiza53 | EVP, Chf Gl Pdt Str &Oper Ofc | Sale+OE | 5,564 | $50.42 | $280,520.19 | -14.1% | -19.0% | -37.1% | |
| Jan 17, 2024 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 7,744 | $50.42 | $390,429.25 | -12.7% | -19.0% | -37.1% | |
| Jan 17, 2024 | Birchler Brian52 | EVP, Corp And Development Ops | Sale+OE | 4,497 | $50.42 | $226,725.25 | -9.2% | -19.0% | -37.1% | |
| Jan 17, 2024 | Swayze Eric63 | EVP Research | Sale+OE | 6,305 | $50.42 | $317,879.19 | -12.7% | -19.0% | -37.1% | |
| Jan 17, 2024 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 5,482 | $50.42 | $276,385.99 | -10.3% | -19.0% | -37.1% | |
| Jan 17, 2024 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 7,338 | $50.42 | $369,959.95 | -7.9% | -19.0% | -37.1% | |
| Jan 17, 2024 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 6,745 | $50.42 | $340,062.67 | -8.0% | -19.0% | -37.1% | |
| Jan 17, 2024 | Baroldi Joseph52 | EVP, Chief Business Officer | Sale+OE | 2,024 | $50.42 | $102,044.01 | -12.3% | -19.0% | -37.1% | |
| Jan 17, 2024 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 8,683 | $50.42 | $437,770.81 | -8.7% | -19.0% | -37.1% | |
| Jan 12, 2024 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 8,000 | $53.50 | $427,999.20 | -17.3% | -20.6% | -37.5% |